Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743610 · ClinicalTrials.gov registry record · NA
Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance
A NA study of Altitude Hypoxia, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT03743610 is a NA study of Altitude Hypoxia that has completed, run by Mayo Clinic. The registered enrollment target is 71 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03743610, a NA study of Altitude Hypoxia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators expect to find that different intensity and altitude exposure levels will show what kind of intermittent exposure protocol is more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise. This may furthermore be related to acute altitude exposure for recreational exercise use as well.
Conditions Studied
Interventions
- OTHER Simulated altitude
- OTHER Placebo simulated altitude
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03743610
The ClinicalTrials.gov registry entry for NCT03743610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Altitude Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Simulated altitude is the first listed.
NCT03743610 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03743610 about?
NCT03743610 is a clinical study titled "Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance". The investigators expect to find that different intensity and altitude exposure levels will show what kind of intermittent exposure protocol is more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise. This may furthermore be related to acute alt...
What is the current status of trial NCT03743610?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2019-01-01. Estimated completion is 2023-10-25.
What conditions does trial NCT03743610 study?
This clinical trial studies the following conditions: Altitude Hypoxia.
What interventions are being tested in trial NCT03743610?
The interventions under investigation include: Simulated altitude (OTHER), Placebo simulated altitude (OTHER).
Who is sponsoring clinical trial NCT03743610?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03743610 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Altitude Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.